Details of the Drug Combinations

General Information of This Drug (ID: DMFY0MX)

Drug Name

Sivextro DMFY0MX

Synonyms

Tedizolid phosphate; Torezolid phosphate; 856867-55-5; Tedizolid (phosphate); UNII-O7DRJ6R4DW; CHEBI:83326; O7DRJ6R4DW; TR-701; TR-701 FA; TR-701-FA; (R)-(3-(3-fluoro-4-(6-(2-methyl-2H-tetrazol-5-yl)pyridin-3-yl)phenyl)-2-oxooxazolidin-5-yl)methyl dihydrogen phosphate; NE63553; [(5R)-3-{3-fluoro-4-[6-(2-methyl-2H-tetrazol-5-yl)pyridin-3-yl]phenyl}-2-oxo-1,3-oxazolidin-5-yl]methyl dihydrogen phosphate; (R)-3-(4-(2-(2-methyltetrazol-5-yl)pyridin-5-yl)-3-fluorophenyl)-5-hydroxymethyloxazolidin-2-one dihydrogenphos

Indication

Disease Entry	ICD 11	Status	REF
Acute bacterial skin infection	1C41	Phase 3	[1]
------------------------------------------------------------------------------------

Structure

3D MOL

2D MOL

List of Combinatorial Drugs (CBD) Containing This Drug

1 Clinical Trial Drug Combination(s) Consisting of This drug

DrugCom Name	DrugCom ID	Component Drug	Indication	REF
Sivextro + Rosuvastatin	DCTY45U	Rosuvastatin	Skin Diseases, Bacterial	[2]
------------------------------------------------------------------------------------

References

1	Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
2	ClinicalTrials.gov (NCT02477514) A Study to Evaluate the Effects of Tedizolid Phosphate on the Pharmacokinetics and Safety of Midazolam and Rosuvastatin (MK-1986-004)